Christopher Kelly reports on FDA.gov that The U.S. Food and Drug Administration (FDA), in partnership with international regulatory and law enforcement agencies, took action this week against more than 9,600 websites that illegally sell potentially dangerous, unapproved prescription medicines to consumers. A motivating factor behind the action was the 6th annual International Internet Week of Action (IIWA), a global combative against the online sale and distribution of illegal and counterfeit medicines. One piece of this year’s campaign was Operation Pangea VI, which used the FDA’s Office of Criminal Investigations partnering with the US District Attorney’s Office to seize and shut down almost 1,700 illegal online operations. The effort running from June 18 to June 25, 2013 targeted illegal sites using large brand names and “FDA approved” labels to sell non approved drugs that look similar to Avandaryl, Celebrex, Viagra, Levitra, and Clozaril. The aim of this effort is the protection of citizens against illegal medical products. How much emphasis do you think the FDA should put into this initiative? For the full article, click here.
Obstacles Facing Biosimilars
Still in its infancy in the U.S., the industry faces some growing pains.
Life Science Accelerated
Our experts are dedicated to expediting life science product development regulatory pathways.